Skip to main content
. 2021 Oct 21;6(4):e21.00085. doi: 10.2106/JBJS.OA.21.00085

Fig. 4.

Fig. 4

Univariate analysis. An odds ratio (OR) of >1 favors clinical success (defined as ≥50% reduction in WOMAC at 12 months).